Dr. Loren Pickart, PhD (1938–2023)
Biography & Research Background
Loren Pickart, PhD, was a biochemist at the University of California, San Francisco (UCSF), and the discoverer of GHK-Cu. He isolated GHK from human plasma albumin in 1973 and identified its ability to make old liver tissue synthesize younger protein profiles. He founded ProCyte Corporation (1985–1991) and Skin Biology, Inc. to commercialize copper peptide products. In later years, he used the Broad Institute Connectivity Map to demonstrate GHK modulates >4,000 human genes. Key publications: 'Tripeptide in human serum which prolongs survival of normal liver cells' (1973), 'Growth-modulating plasma tripeptide may function by facilitating copper uptake into cells' (1980, Nature), 'The human tri-peptide GHK and tissue remodeling' (2008), 'GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration' (2015), 'Regenerative and Protective Actions of the GHK-Cu Peptide' (2018). Loren Pickart is referenced as the foundational scientist in GHK-Cu research. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure US Peptide and this doctor.
External Profiles
Authored Research Profiles (1)
Dr. Loren Pickart, PhD (1938–2023) is referenced as a leading researcher in the following peptide research profiles on Pure U.S. Peptides:
Dr. Loren Pickart, PhD (1938–2023) is being referenced as one of the leading scientists involved in the research and development of the peptides listed above. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of any product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure U.S. Peptides and this researcher. The purpose of citing the researcher is to acknowledge, recognize, and credit the exhaustive research and development efforts conducted by the scientists studying these peptides.